









Markets
/
Stocks
/
nasdaq-dmiiu
/

Drugs Made In America Acquisition II Units

DMIIU

10.020USD

0.000

Close 12/10, 16:00（ET）Quotes delayed by 15 min

657.06MMarket Cap

--P/E TTM



Drugs Made In America Acquisition II Units

10.020

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Drugs Made In America Acquisition II Units here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--315.09K

- Cash and cash equivalents

--315.09K

Receivables

--566.27K

-Other receivables

--566.27K

Prepaid expenses

--15.00K

Total current assets

--896.36K

Non-current assets

Other non-current assets

--500.11M

Total non-current assets

--500.11M

Total assets

--501.01M

Liabilities

Current liabilities

-Other payables

--553.75K

Accrued expenses

--119.00K

Short-term debt and lease liabilities

--0.00

-Short-term debt

--0.00

Other current liabilities

--553.75K

Total current liabilities

--677.35K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

--17.50M

Total non-current liabilities

--17.50M

Total liabilities

--18.18M

Shareholders' equity

Common equity

--500.11M

Retained earnings

---17.28M

Total equity

--482.83M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

